Intravesical immunotherapy
Showing 1 - 25 of 3,594
Bladder Cancer Trial in Switzerland (Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC), Atezolizumab, Cisplatin)
Recruiting
- Bladder Cancer
- Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC)
- +3 more
-
Baden, Switzerland
- +9 more
Aug 12, 2022
Urinary Bladder Tumors, Immunotherapy Trial in Shanghai (Camrelizumab)
Recruiting
- Urinary Bladder Neoplasms
- Immunotherapy
-
Shanghai, Shanghai, China
- +3 more
Oct 9, 2021
Urinary Bladder Cancer Trial in Tucson (Gemcitabine)
Not yet recruiting
- Urinary Bladder Cancer
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 21, 2022
Urothelial Carcinoma Bladder, Sperm Count, Low, Testis; Fibrosis Trial (Bacillus Calmette Guerin)
Not yet recruiting
- Urothelial Carcinoma Bladder
- +2 more
- Bacillus Calmette Guerin
- (no location specified)
Jan 18, 2023
Bladder Cancer Trial in Mansoura (Intravesical Bcg, Intravesical chemo (epirubicin))
Recruiting
- Bladder Cancer
- Intravesical Bcg
- Intravesical chemotherapy (epirubicin)
-
Mansoura, DK, EgyptMansoura Urology and Nephrology Center
Dec 21, 2021
Bacillus Calmette Guerin With Use of Different Types of Urinary
Completed
- Non-muscle-invasive Bladder Cancer
-
Marathon, Attica, GreeceThemistoklis Bellos
Jan 10, 2023
Neutrophils to Lymphocytes Ratio in Predicting Response to BCG
Completed
- Urinary Bladder Cancer
- +4 more
- Neutrophil to lymphocyte ratio
-
Cairo, EgyptAin Shams university
Jul 15, 2023
Mitochondrial Functionality in Carcinoma of Urinary Bladder:
Unknown status
- Bladder Cancer
- No intervantion on patients. retrospective study is performed on paraffin embedded tumor tissue specimens routinely collected during TURBT.
-
Rozzano, Milan, ItalyHumanitas reseach hospital (ICH)
Feb 12, 2020
Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Durvalumab (Cohort 1-3)
- +7 more
-
Phoenix, Arizona
- +10 more
Jan 11, 2023
Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- BCG combined with Tislelizumab
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Oct 12, 2022
Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy
Recruiting
- Urothelial Carcinoma
- Radiotherapy
- +2 more
-
Beijing, China
- +2 more
Nov 2, 2023
Urinary Bladder Wall Post Transurethral Tumor Resection
Not yet recruiting
- Urinary Bladder Cancer
- MRI
- (no location specified)
Mar 15, 2023
Analyzing Urine During BCG Instillation in Bladder Cancer
Not yet recruiting
- Bladder Cancer
- urine sample collection
-
Shanghai, Shanghai, ChinaChanghai Hospital
Nov 30, 2023
Bladder Cancer, Bacillus Calmette-Guerin Trial in Campinas (Bacillus Calmette Guerin, PLACEBO)
Active, not recruiting
- Bladder Cancer
- Bacillus Calmette-Guerin
- Bacillus Calmette Guerin
- PLACEBO
-
Campinas, SP, BrazilHospital das Clínicas Unicamp
May 18, 2022
Intravesical Therapy and Surgery as Treatment Options for
Recruiting
- Bladder Cancer
- +2 more
-
Birmingham, Alabama
- +37 more
Nov 28, 2022
Non Muscle Invasive Bladder Cancer Trial in Lausanne (Ty21a)
Recruiting
- Non Muscle Invasive Bladder Cancer
- Ty21a
-
Lausanne, Vaud, SwitzerlandDpt Urology- CHUV
Apr 27, 2021
Non-Muscle Invasive Bladder Cancer Trial in Shanghai (VB4-845 Injection)
Recruiting
- Non-Muscle Invasive Bladder Cancer
- VB4-845 Injection
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 21, 2021
Bladder Cancer Trial in Saint Herblain (89Zr-TLX250 PET/CT)
Recruiting
- Bladder Cancer
- 89Zr-TLX250 PET/CT
-
Saint Herblain, FranceInstitut de cancerologie de l'Ouest
Nov 24, 2021
Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Trial in Canada, United States (TLD-1433 Bladder infusion and
Recruiting
- Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
- TLD-1433 Bladder infusion and Photodynamic Therapy
-
Bala-Cynwyd, Pennsylvania
- +10 more
May 6, 2022
Bladder Cancer Trial in Canada, United States (Vicinium)
Active, not recruiting
- Bladder Cancer
- Vicinium
-
Birmingham, Alabama
- +69 more
Jun 10, 2021
Bladder Cancer Trial in Houston (Bladder tumor biopsy)
Recruiting
- Bladder Cancer
- Bladder tumor biopsy
-
Houston, TexasBaylor College of Medicine
Jan 14, 2022
Invasive Bladder Cancer Trial in Spain (Durvalumab, Tremelimumab, Radiotherapy)
Active, not recruiting
- Invasive Bladder Cancer
- Durvalumab
- +2 more
-
Badalona, Barcelona, Spain
- +6 more
Mar 9, 2022